Skip to main content
Filing year 2024

CONGENITAL HYPERINSULINISM INTERNATIONAL

Glen Ridge, New Jersey·EIN 20-3068945·NTEE G12 · Diseases, Disorders & Medical Disciplines·501(c)(3)
Total revenue
$1.3M
Total assets
$2.2M
Total expenses
$1.1M
Reported officers
10
Mission

Congenital Hyperinsulinism International (CHI) is a nonprofit 501(c)(3) corporation dedicated to improving the lives of babies, children, and adults affected by congenital hyperinsulinism (HI). HI is a life-threatening genetic disorder that causes severe low blood sugar (hypoglycemia) in infants and children, though in 50% of patients, the genetic cause is unknown. For those with HI, the beta cells of the pancreas secrete too much insulin in an unregulated manner. Excess insulin causes hypoglycemia. Prolonged or severe hypoglycemia can cause seizures, permanent brain damage, or even death if left untreated. A good prognosis is far more likely with a timely diagnosis and proper management.

Executive compensation

Form 990 · Part VII & Schedule J · 3 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at Diseases, Disorders & Medical Disciplines organizations in New Jersey.

CEO
25th percentile to median
$114k
$123k
Cro
Officer (Unspecified)
$95k
$103k
COO
10th to 25th percentilevs Diseases, Disorders & Medical Disciplines peers nationwide
$90k
$97k

Teal figures restate each filed amount in 2026 dollars.

Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 7 unpaid individuals.

Browse compensation in Diseases, Disorders & Medical Disciplines

Pay in context

Top pay as a share of expenses

In 2024, the highest total compensation at CONGENITAL HYPERINSULINISM INTERNATIONAL equaled 10% of the organization's total expenses. The median for diseases, disorders & medical disciplines organizations is 10%.

This organization (2024)
10%
Sector median
10%
Middle half of sector
4% to 22%

Based on 2,393 diseases, disorders & medical disciplines organizations, each measured at its most recent filing year with reported expenses and compensation.

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Up 10%
from 2023

From $104k in 2023 to $114k in 2024.

$104k
2023
$114k
2024
In today's dollarsEst.
Up 6% in real terms$116k to $123k

Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Pay for the position

Chief Executive Officer pay rose 10% from 2023 to 2024, while revenue rose 11%.

$104k in 2023 to $114k in 2024.
  • Chief Operating Officer pay rose 13% from 2023 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

FAQ

Common questions about CONGENITAL HYPERINSULINISM INTERNATIONAL

What does the Chief Executive Officer of CONGENITAL HYPERINSULINISM INTERNATIONAL earn?

In 2024, the Chief Executive Officer of CONGENITAL HYPERINSULINISM INTERNATIONAL received $114,071 in total compensation. This pay is below the median (the midpoint) for Chief Executive Officer roles among Diseases, Disorders & Medical Disciplines organizations in New Jersey, but above the bottom quarter of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at CONGENITAL HYPERINSULINISM INTERNATIONAL compare with similar nonprofits?

Compared with the same role at Diseases, Disorders & Medical Disciplines organizations in New Jersey, the 2024 pay of the Chief Executive Officer at CONGENITAL HYPERINSULINISM INTERNATIONAL falls between the 25th percentile and the median. In 2024, the highest total compensation at CONGENITAL HYPERINSULINISM INTERNATIONAL equaled 10% of the organization's total expenses. The median for diseases, disorders & medical disciplines organizations is 10%.

What are CONGENITAL HYPERINSULINISM INTERNATIONAL's revenue and expenses?

In 2024, CONGENITAL HYPERINSULINISM INTERNATIONAL reported $1.3M in total revenue and $1.1M in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.